Megestrol, which helps treat hot flashes associated with menopause, may have the added benefit of slowing the growth of ...

IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist, designed for durable weight management with improved ...

Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and ...

Invested $269 Million in Convenience and Automotive Retail Assets - - Introduces 2026 Earnings Guidance - NEW YORK, Jan. 08, 2026 (GLOBE ...

Leaders say they are looking forward to the completion of long-awaited projects, ready for new ones and are working to ensure ...

IND filing of ALV-200 and advancement of additional programs across the R&D pipeline ALV-100, a bifunctional GIPR antagonist / GLP-1R agonist, designed ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal ...

Up until recently, all three GLP-1 drugs for weight loss were only available in injectable form. However, the FDA approved ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

Under 19 Cricket Tissa Central, Kalutara produced a stunning nine wicket victory over Zahira College, Maradana as spinner and ...

The first T20 International against Pakistan in Dambulla underlined, yet again, how heavily Sri Lanka lean on their ...

Trump rang in 2026 with threats against Iran and a stunning grab for Venezuela, signaling a volatile new world order driven ...